wisepowder: Germany Announces Opening of its Life Science Business’ Largest M Lab Collaboration Center in Shanghai
Germany Announces Opening of its Life Science Business’ Largest M Lab Collaboration Center in Shanghai
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the opening of a M LabTM Collaboration Center in Shanghai, the largest of nine centers worldwide operated by the company’s Life Science business.To get more shanghai breaking news, you can visit shine news official website.
“With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase in R& on leading-edge treatments including cell and gene therapies in China,” said Udit Batra, member of the Executive Board and CEO, Life Science business of Merck KGaA, Darmstadt, Germany. “Our M LabTM Collaboration Center offers customizable solutions and services that help bio pharmaceutical and biologics companies improve their processes from drug discovery, development to manufacturing — saving costs and increasing speed to market.
” With a total lab size of approximately 10,000m2, the newest M LabTM Collaboration Center is located in Pudong, at the heart of the biomedical sciences and research community in Shanghai. The new M LabTM Collaboration Center in Shanghai offers customizable solutions tailored for China’s Life Science community to help advance drug development. It includes Pilot Scale and Process Development support labs that offer non-GMP (Good Manufacturing Practice) lab space where pharmaceutical and biopharmaceutical manufacturers can explore ideas, learn innovative techniques and work side-by-side with the company’s scientists and engineers to solve critical process development and production challenges. Customers can participate in product demonstrations, hands-on training, formal bioprocessing educational courses and experiments, as well as apply best practices and new approaches to develop, optimize and scale-up processes and simplify global technology transfer.
Additionally, the center will host a new BioReliance® End-to-End Solutions GMP manufacturing facility offering contract development manufacturing organization services to customers in China and Asia-Pacific. As a leading innovator in the pharmaceutical and biopharmaceutical industry, the Life Science business of Merck KGaA, Darmstadt, Germany is committed to playing an active role in China’s transformation into an innovation- driven economy. Through this new center, the business will collaborate with local and regional customers to increase drug quality and safety and provide training and knowledge transfer.
Add comment
Comments